IPP Bureau
K J Somaiya Hospital & Research Centre launches advanced neurosciences centre in Mumbai
By IPP Bureau - November 08, 2024
The centre is equipped with the most modern tools and provides an environment soothing for all professionals and patients
Emcure Pharmaceuticals posts Q2 FY25 consolidated PAT at Rs. 194.57 Cr
By IPP Bureau - November 08, 2024
Emcure Pharmaceuticals has reported total income of Rs. 2,037.63 crores during the period ended September 30, 2024
Abbott India reports Q2 FY25 standalone PAT at Rs. 358.61 Cr
By IPP Bureau - November 08, 2024
The company has reported total income of Rs. 1,693.15 crores during the period ended September 30, 2024
Medanta to operate and manage 750 bed super speciality hospital in Pitampura, New Delhi
By IPP Bureau - November 08, 2024
Medanta is expected to incur a project capex of ~Rs. 600 crores in next 3-4 years
Neuland Laboratories Q2 FY25 consolidated PAT falls to Rs. 32.84 Cr
By IPP Bureau - November 08, 2024
Neuland Laboratories has reported total income of Rs. 315.17 crores during the period ended September 30, 2024
JB Pharma posts Q2 FY25 PAT 16% higher at Rs. 175 Cr
By IPP Bureau - November 07, 2024
JB’s domestic business continued to out-perform the market with all our major brands posting strong growth
KIMS to acquire 3,000 beds in next 5 years in Kerala
By IPP Bureau - November 07, 2024
The group plans to establish new hospitals in Kerala developing large health cities in Kochi and Kozhikode
Mitsui Chemicals begins sale of i-TFC luminous II dental material range
By IPP Bureau - November 07, 2024
The new range incorporates a product that also contains the S-PRG filler employed in the Giomer range
Mitsui Chemicals invests in clinical kidney disease drug developer Rege Nephro
By IPP Bureau - November 07, 2024
The company uses iPS cells to develop treatments for diseases relating to the kidney
Max Healthcare posts Q2 FY25 consolidated PAT at Rs. 281.81 Cr
By IPP Bureau - November 07, 2024
Max Healthcare Institute has reported total income of Rs. 1,748.30 crores during the period ended September 30, 2024
Apollo Hospitals reports Q2 FY25 consolidated PAT at Rs. 378.8 Cr
By IPP Bureau - November 07, 2024
Apollo Hospitals Enterprise has reported total income of Rs. 5,627.5 crores during the period ended September 30, 2024
Ichnos Glenmark Innovation to present Phase 1 study of Trispecific ISB 2001 in r/rMM at ASH Annual Meeting
By IPP Bureau - November 07, 2024
ISB 2001 demonstrated a favorable safety and tolerability profile, and an overall response rate (ORR) of 75% in r/r MM
Alembic Pharmaceuticals Q2 FY25 PAT up 12% to Rs. 153 Cr
By IPP Bureau - November 07, 2024
US Generics grew 5% to Rs. 467 Crores for the quarter
Vijaya Diagnostic Centre posts Q2 FY25 PAT at Rs. 41.95 Cr
By IPP Bureau - November 07, 2024
Revenue growth was fueled by higher volumes and contributions from both existing and new centres
